# Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Study · id `cardio:ct-nct02407457` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02407457](<https://clinicaltrials.gov/study/NCT02407457>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02407457

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 455 participants.

## Technical summary

Registry record NCT02407457. Randomized; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2018-10 (actual). Results posted on 2020-09-21.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 455 participants (enrolled count; ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Started: 2015-03 (actual) (ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Primary completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Completion: 2022-10 (actual) (ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Results first posted: 2020-09-21 (ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02407457, source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02407457-2024-10-01`, retrieved 2026-11-18)

## The registry's words

- Brief title: Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices
- Acronym: LEOPARD
- Condition: Abdominal Aortic Aneurysm
- Intervention (Device): AFX EVAR AAA Graft System
- Intervention (Device): FDA Approved EVAR AAA Graft Systems
- Lead sponsor: Endologix
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Endologix (`cardio:org-endologix`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-year results of the LEOPARD trial of commercially available endografts (`cardio:pubmed-37068528`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c7018788a15d2c94f85e8c6bde978d582b4a82c3604841d803d47775483e0099
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
